Loading...

Table of Content

    15 April 2022 Volume 40 Issue 4
      
    Changes in viral etiology of children with respiratory tract infection and diagnostic strategy during the COVID-19 pandemic
    WANG Yuqing, JIANG Wujun, GU Wenjing
    Journal of Clinical Pediatrics. 2022, 40(4):  241-246.  doi:10.12372/jcp.2022.22e0195
    Abstract ( 566 )   HTML ( 51 )   PDF (1225KB) ( 380 )  
    References | Related Articles | Metrics

    Respiratory tract infection is the commonest infectious disease in childhood, and virus is the main pathogen. Since the outbreak of coronavirus disease 2019 (COVID-2019), the epidemiological characteristics and spectrum of respiratory tract pathogens in children have changed. Etiological detection and continuous monitoring are of great significance and can provide evidence for clinical diagnosis, treatment and prevention and control.

    Clinical indicators related to prognosis of Mycoplasma pneumoniae pneumonia
    LIU Feng
    Journal of Clinical Pediatrics. 2022, 40(4):  247-251.  doi:10.12372/jcp.2022.22e0170
    Abstract ( 447 )   HTML ( 42 )   PDF (1231KB) ( 340 )  
    References | Related Articles | Metrics

    Mycoplasma pneumoniae (MP) results in community-acquired pneumonia in children by causing direct damage and immune damage to respiratory tissue. At present, refractory Mycoplasma pneumoniae pneumonia (RMPP), MPP complications such as bronchial mucous plugs, bronchiolitis obliterans, etc., have increased significantly. Therefore, it is very important to grasp the clinical indicators for the prediction and diagnosis of RMPP and MPP-related complications for the prognosis of childhood diseases.

    Clinical features of 54 children infected with SARS-CoV-2 delta variant in Yangzhou area
    LYU Yuan, SHU Guihua, HOU Weiwei, LU Xingxing, YUAN Min, WANG Yueyuan, TAO Yuehong
    Journal of Clinical Pediatrics. 2022, 40(4):  252-257.  doi:10.12372/jcp.2022.21e1264
    Abstract ( 340 )   HTML ( 10 )   PDF (1179KB) ( 142 )  
    Figures and Tables | References | Related Articles | Metrics
    Objective To investigate the clinical characteristics of SARS-CoV-2 delta variant in children and the similarities and differences between children and adults.Methods The clinical data of 54 children infected with SARS-COV-2 delta variant in Yangzhou were retrospectively analyzed and were compared with those of adults who were diagnosed in the same period.Results There were 35 boys and 19 girls in the children group and the mean age was (8.1±3.4) years. In the adult group, there were 37 patients (23 boys and 14 girls), and the mean age was (33.4±7.6) years. Compared with the adult group, the children group had a higher proportion of mild cases, a lower proportion of vaccination, a lower proportion of respiratory symptoms, a higher level of CK-MB, a lower level of CRP and IL-6, and a lower titer of SARS-CoV-2 IgG and IgM antibodies on admission, and the differences were statistically significant (P<0.05). No antibiotics or glucocorticoids were given in 2 groups. The patients were mainly treated with traditional Chinese medicine, posture therapy and symptomatic treatment, and the prognosis were good. The time from onset to disappearance of clinical symptoms was 4.0 (2.0-7.0) days in the children group and 7.0 (4.2-10.8) days in the adult group, and the difference between the two groups was statistically significant (P<0.01). The peak values of SARS-CoV-2 IgG and IgM antibodies in the children group were lower than those in the adult group, and the differences were statistically significant (P<0.05).Conclusions Children are also susceptible to the SARS-COV-2 delta variant, with a higher proportion of mild infection. Furthermore, children are more likely to have myocardial injury and recover faster than adults.
    Analysis of high-risk factors of bronchial mucus plugs formation in children with lobar pneumonia
    SU Yanyan, TANG Yu, WANG Yanqiong, XU Shasha, DONG Lili
    Journal of Clinical Pediatrics. 2022, 40(4):  258-262.  doi:10.12372/jcp.2022.21e0199
    Abstract ( 346 )   HTML ( 9 )   PDF (1205KB) ( 152 )  
    Figures and Tables | References | Related Articles | Metrics
    Objective To investigate the clinical characteristics and high-risk factors of bronchial mucus plugs formation in children with lobar pneumonia.Methods Children with lobar pneumonia treated from January 2018 to March 2020 were selected as the study subjects. According to the results of fiberoptic bronchoscopy, the children were divided into the mucous plugs group and the non-mucous plugs group, and the clinical characteristics and laboratory examination results of the two groups were compared.Results A total of 935 children with lobar pneumonia were treated. According to fiberoptic bronchoscopy, 135 patients (73 boys and 62 girls) were included in the mucous plugs group, and the median age was 5.0 (3.1-7.0) years. There were 135 children (75 boys and 60 girls) in the non-mucous plugs group, and the median age was 5.8 (4.0-7.0) years. Compared with the non-mucous plugs group, the mucous plugs group had a longer fever duration, a higher percentage of neutrophil, higher levels of c-reactive protein (CRP), procalcitonin (PCT), lactate dehydrogenase (LDH), D-2 dimer and CD4/CD8, and a lower platelet count, with statistical significance (P<0.05). Mycoplasma pneumoniae was the main pathogen in both groups. The proportions of Mycoplasma pneumoniae infection, Mycoplasma pneumoniae combined with bacterial infection, Mycoplasma pneumoniae combined with virus infection and Mycoplasma pneumoniae combined with Epstein-Barr virus infection in the mucous plugs group were 92.6%, 20.7%, 51.1% and 14.1%, respectively, which were higher than 77.0%, 11.9%, 20.0% and 0.7% in the non-mucous plugs group, and the differences were statistically significant (χ2=3.91-28.51, P<0.05). The proportion of infection sites in the lower lobe of lung and left lower lobe of lung in the mucus plugs group was higher than that in the non-mucus plugs group, and the incidence of pleural effusion, liver function injury and sequelae was higher than that in the non-mucus plugs group, and the differences were statistically significant (P<0.05). The results of binary logistic regression analysis suggested that LDH and CD4/CD8 were independent risk factors for the formation of mucous plugs in lobar pneumonia (P<0.05).Conclusions The formation of bronchial mucus plugs in children with lobar pneumonia is related to LDH and CD4/CD8.
    Analysis of related factors of serum PT-IgG concentration in children with pertussis diagnosed by etiology
    GAN Chuan, WU Xiaoying, XU Hongmei
    Journal of Clinical Pediatrics. 2022, 40(4):  263-267.  doi:10.12372/jcp.2022.21e0566
    Abstract ( 415 )   HTML ( 7 )   PDF (1173KB) ( 172 )  
    Figures and Tables | References | Related Articles | Metrics
    Objective To investigate the relative factors of serum pertussis toxin antibodies (PT-IgG) in children with pertussis.Methods Clinical data of children hospitalized with pertussis from April 1, 2018 to July 31, 2019 were retrospectively analyzed. To analyze the influence of different course of disease, pertussis vaccine dose, onset age and disease severity on PT-IgG level in children with pertussis. Result A total of 638 children were included. In the unvaccinated group, 313 patients (177 boys and 136 girls) had a median age of 78.0 (52.0-125.0) days. In the vaccination group, there were 325 patients (163 boys and 162 girls) with a median age of 232.0 (144.0-483.0) days. There were statistically significant differences in the distribution of PT-IgG levels among different disease course groups at sampling (≤14d, 15-21d, >21d) in the unvaccinated group (P<0.01). The proportion of PT-IgG≥80 IU/mL was higher in patients with disease course >21 days. There was significant difference in PT IgG level between different vaccine groups (P<0.01). The proportion of PT-IgG≥80 IU/mL was higher in patients with disease course of 15~21 days and >21 days. There were statistically significant differences in PT-IgG levels between groups receiving different doses of vaccine (P<0.01). The levels of PT-IgG gradually increased with the increase of vaccine doses. In the unvaccinated group, no matter in the severe group or the normal group, the difference of PT-IgG level among different disease course groups at sampling was statistically significant (P<0.05). In the inoculation group, the difference of PT-IgG levels among different disease course groups at sampling in the normal group was statistically significant (P<0.05).Conclusions The level of PT-IgG in children with acute infection of Bordetella pertussis in China was not high, and 59.9% of them had a PT-IgG level lower than 20IU/mL. PT-IgG levels were affected by the dose of vaccine and the course of disease at the time of sampling.
    Etiological analysis of 690 cases of pneumonia complicated with atelectasis
    LI Yuehan, LIU Zheng, FU Zhou, YANG Zhimei
    Journal of Clinical Pediatrics. 2022, 40(4):  268-273.  doi:10.12372/jcp.2022.21e0706
    Abstract ( 282 )   HTML ( 8 )   PDF (1183KB) ( 189 )  
    Figures and Tables | References | Related Articles | Metrics
    Objective To study the etiological characteristics of pneumonia complicated with atelectasis in the city of Chongqing.Methods The clinical data of 690 children with pneumonia complicated with atelectasis were collected, and a retrospective analysis was performed on the characteristics of pathogen, involved lobes and the clinical effect of bronchoalveolar lavage.Results A total of 690 children (353 boys and 337 girls) were included and the median age was 4.1 (2.5~6.8) years. Among them, 601 children (87.1%) had definite pathogens. Mycoplasma pneumoniae was the commonest pathogen (330 cases, 47.8%), followed by bacteria (271 cases, 39.3%) and virus (209 cases, 30.3%). There were significant differences in pathogen distribution among different age groups and different season groups (P<0.001). The proportion of bacteria, virus and bacteria combined with virus infection was higher in infant and young children group. The proportion of mycoplasma infection was higher in preschool and school-age children. The proportion of bacterial infection was higher in spring and autumn, that of virus infection was higher in winter, and that of mycoplasma infection was higher in summer and autumn. There were statistically significant differences in the predisposition sites of pneumonia with atelectasis among different age groups (P<0.001). The proportion of atelectasis in the upper lobe of the right lung was higher in the infant group, and that in the middle lobe of the right lung was higher in the young children, pre-school age and school age groups. The frequency of bronchoalveolar lavage was significantly correlated with the type of pathogen and the number of affected lobes (P<0.01). The proportion of one time of bronchoalveolar lavage in children with single pathogen infection and single lobe atelectasis was high.Conclusions Mycoplasma pneumoniae is the commonest pathogen of pneumonia complicated with atelectasis, and there are differences in pathogen composition among different ages and seasons. The main involved lobe is the right middle lobe. The prognosis is closely related to the pathogen of infection and the number of affected lobes, and refractory atelectasis is easily caused by mixed infection and multilobed atelectasis.
    Clinical features and curative effect analysis of pleural tuberculoma in children
    YUAN Yeling, ZHANG Feng, WANG Tuanmei
    Journal of Clinical Pediatrics. 2022, 40(4):  274-278.  doi:10.12372/jcp.2022.21e1202
    Abstract ( 235 )   HTML ( 7 )   PDF (1769KB) ( 157 )  
    Figures and Tables | References | Related Articles | Metrics
    Objective To investigate the clinical imaging features and efficacy of pleural tuberculoma (PTM) in children, and to improve the understanding of this disease.Methods The clinical date of 36 children diagnosed with PTM were retrospectively analyzed.Results Among the 36 patients (24 boys and 12 girls), 26 were from rural areas and 10 were from urban areas, and the median age was 10.0 (7.3-13.8) years. Four children were 0-5 years old, 11 were 5-10 years old, 12 were 10-14 years old, and 9 were >14 years old. All the children had a clear history of tuberculous pleurisy. Chest CT scans showed typical manifestations of PTM, including single lesions in 30 cases and multiple lesions in 6 cases. The lesions were located on the right side in 22 cases, on the left side in 12 cases, and on both sides in 2 cases. Isoniazid combined with rifampicin and pyrazinamide were used as the main anti-tuberculosis regimen. PTM was found in 24 patients less than 3 months after anti-tuberculosis treatment, 9 patients between 3 and 6 months after treatment, and 3 patients after 6 months of treatment. After the diagnosis of PTM, 25 children were treated with the original regimen, 4 were treated with linezolid and 3 with ethambutol in combination, and 4 were treated with surgery. Finally, 34 children were cured and 2 were under treatment.Conclusions Children's PTM mostly occurs in older boys with tuberculous pleurisy within 3 months of anti-tuberculosis treatment. Chest CT is helpful for diagnosis, and most of the children can be cured by medical treatment.
    Epidemiological characteristics and drug resistance analysis of respiratory tract infections in hospitalized children caused by Moraxelle catarrhalis in Suzhou area
    WU Yinyin, ZHANG Liya, TAO Yunzhen, HUANG Lili, JI Wei
    Journal of Clinical Pediatrics. 2022, 40(4):  279-283.  doi:10.12372/jcp.2022.21e1254
    Abstract ( 269 )   HTML ( 3 )   PDF (1202KB) ( 221 )  
    Figures and Tables | References | Related Articles | Metrics
    Objective To analyze the epidemiological characteristics and drug sensitivity changes of respiratory tract infections in hospitalized children caused by Moraxelle Catarrhalis (MC) in Suzhou area, so as to provide information for the rational use of antibiotics in clinic.Methods The results of bacterial culture in nasopharyngeal secretions of hospitalized children with respiratory tract infection from January 2008 to December 2020 were collected. The children were divided into groups according to age, season and basic diseases. The epidemic characteristics of MC infection were monitored and the changes of MC drug sensitivity were dynamically observed.Results A total of 27 472 specimens of nasopharyngeal secretions from children with respiratory tract infections were collected in the past 13 years, of which 742 specimens were cultured with MC, and the total detection rate of MC was 2.7%. There were significant differences in MC detection rates among different years from 2008 to 2020 (P<0.01), and the detection rate in 2017 was higher. There was significant difference in the detection rate of MC among different age groups (P<0.01). The detection rate was higher in 3-5 years, and lower in >5 years. The difference of MC detection rate among spring, summer, autumn and winter was statistically significant (P<0.01) and the detection rate was higher in autumn and lower in summer. Among 27 472 children, 18.9% had basic diseases. The detection rate of MC in the group with concomitant diseases was 1.8%, lower than that in the group without concomitant diseases (2.9%), and the difference was statistically significant (P<0.01). The results of drug susceptibility tests from 2013 to 2020 were summarized, and it was found that MC was highly sensitive to rifampicin, chloramphenicol, cefotaxime, tetracycline and levofloxacin. The sensitivity rate of drug sensitivity test was statistically significant among 8 years (P<0.05). MC also had high sensitivity rate to amoxicillin and cotrimoxazole.Conclusions The children infected with MC in Suzhou were mainly less than 5 years old. Autumn was the frequent season of onset, and MC had a high sensitivity rate to multiple antibiotics. Amoxicillin is recommended as the first treatment for MC infection of respiratory tract in children.
    A preliminary study on characteristics of visual evoked potentials in children with myelin oligodendrocyte glycoprotein immunoglobulin G associated disorders in the acute phase
    CHEN Jinxiao, SUN Jing, YANG Wenmin, WANG Xiaoyue, WANG Xin, YANG Jian
    Journal of Clinical Pediatrics. 2022, 40(4):  284-289.  doi:10.12372/jcp.2022.21e1251
    Abstract ( 243 )   HTML ( 1 )   PDF (1185KB) ( 148 )  
    Figures and Tables | References | Related Articles | Metrics
    Objective To investigate the characteristics of visual evoked potentials (VEP) in children with MOG-IgG associated disorders (MOGAD) in the acute phase.Methods The clinical data of children admitted from May 2018 to February 2020 who were clinically diagnosed with central nervous system idiopathic inflammatory demyelinating diseases (CNS-IIDDs) were retrospectively analyzed. The children were divided into different groups according to the results of serum MOG-antibody detection and whether the optic nerve was involved clinically. The characteristics of VEP between different groups were analyzed.Results Among 67 children with CNS-IIDDS, 29 (43.3%) were in the MOG antibody positive group, and 15 (51.7%) had optic neuritis. There were 38 (56.7%) children in the MOG antibody negative group, and 19 (50.0%) had optic neuritis. The VEP test was examined on both eyes of all children, including 58 eyes in the MOG antibody positive group and 76 eyes in the MOG antibody negative group, obtaining VEP results of 134 eyes in total. Among the 66 eyes in the non-optic neuritis group, the abnormal rate of VEP in the MOG antibody positive group (14/28, 50.0%) was significantly higher than that in the MOG antibody negative group (9/38, 23.7%), and the difference was statistically significant (P<0.05). In the 68 eyes of the optic neuritis group, the proportion of blindness and severe vision impairment in the MOG antibody positive group was higher than that in the MOG antibody seronegative group, and the difference was statistically significant (P<0.05). In 58 eyes of MOG antibody positive group, there was significant difference in the abnormal rate of VEP between groups with different MOG antibody titer (P<0.05). The abnormal rate of VEP increased with the increase of MOG antibody titer.Conclusions VEP can effectively detect subclinical lesions of optic nerve in MOGAD. The probability of visual pathway damage may be higher under the conditions of high MOG antibody titers.
    Clinical efficacy analysis of granulomatous periorificial dermatitis in 6 children
    YANG Yijun, ZHANG Zhen, WANG Yumeng, LI Ming, YAO Zhirong
    Journal of Clinical Pediatrics. 2022, 40(4):  290-293.  doi:10.12372/jcp.2022.21e0988
    Abstract ( 447 )   HTML ( 9 )   PDF (1340KB) ( 429 )  
    Figures and Tables | References | Related Articles | Metrics
    Objectives To summarize the clinical characteristics of granulomatous periorificial dermatitis in children and to observe the efficacy of clarithromycin in the treatment of granulomatous periorificial dermatitis in children.Methods The clinical data of 6 children with granulomatous periorificial dermatitis treated with clarithromycin from December 2018 to March 2021 were retrospectively analyzed and the relevant literature was reviewed.Results Six children (2 boys and 4 girls) with granulomatous periorificial dermatitis were enrolled, and the median age was 5.0 (4.3-5.0) years. The skin lesions were characterized by erythematous papules involving the perioral and perinasal areas in all 6 cases. In addition, 3 cases involved the periocular area, 1 case involved the neck, and 1 case involved the vulva. The median course of the disease was 4.0 (3.3-7.8) months. After diagnosis, 125 mg clarithromycin was given orally, once a day. The median time of skin lesion clearance was 18.0(16.0-19.0) weeks. During the follow-up, no adverse effect was observed. Conclusion Clarithromycin may be effective and safe in the treatment of granulomatous periorificial dermatitis in children.
    Effects of desmopressin on symptoms and sleep quality in children with monosymptomatic nocturnal enuresis
    LYU Lei, WANG Yihe, HU Huijie, ZHAO Ying, LIU Erpeng, ZHANG Yanping, PU Qingsong, YANG Xinghuan, JI Fengping, WEN Jianguo
    Journal of Clinical Pediatrics. 2022, 40(4):  294-299.  doi:10.12372/jcp.2022.21e1237
    Abstract ( 323 )   HTML ( 8 )   PDF (1196KB) ( 178 )  
    Figures and Tables | References | Related Articles | Metrics
    Objectives To investigate the improvement of symptoms and sleep in children with monosymptomatic nocturnal enuresis (MNE) treated with desmopressin (DDAVP). Methods A total of 69 children with MNE who were treated in our clinic from 2018 to 2020 were selected for a 12-week follow-up study of DDAVP treatment. After 12 weeks, the children were divided into improvement group and non-improvement group according to the remission of enuresis, and the effect of DDAVP treatment on enuresis symptoms and sleep quality was analyzed. Results Among the 69 children with MNE enrolled at baseline, 7 dropped out of the follow-up, and 62 were eventually included, including 34 boys and 28 girls, with an average age of (8.77±1.94) years. In all MNE children treated with DDAVP, there were statistically significant differences in the number of enuresis nights, total score of the children's sleep habits questionnaire (CSHQ), occurrence time of enuresis, and sleep time on weekdays and weekends between baseline, weeks 4, 8 and 12 (P<0.05). Compared with baseline, the number of enuresis nights and the total score of CSHQ at week 12 were significantly decreased, and the occurrence time of enuresis and sleep time on weekdays and weekends were significantly prolonged, and the differences were statistically significant (P<0.05). Compared with the non-improvement group (n=22), the improvement group (n=40) at week 8 and 12 had lower CSHQ scores, significantly longer enuresis occurrence time, sleep time on weekdays and weekends, and fewer enuresis nights per week, and the differences were statistically significant (P<0.05). In terms of CSHQ scores at 8 levels, there were statistically significant differences in the scores of sleeping habits, sleep latency, bedtime duration, sleep anxiety, night waking, parasomnias and daytime sleepiness in the improvement group (P<0.05), while there was statistically significant difference only in bedtime duration in the non-improvement group (P<0.05).Conclusion DDAVP treatment for 12 weeks can significantly improve the symptoms and sleep quality of children with MNE.
    Early-onset epileptic encephalopathy type 27 caused by missense variation of GRIN2B gene: a case report
    MEI Daoqi, MEI Shiyue, WANG Xiaona, WANG Yuan, CHEN Guohong, YANG Zhixiao, CHEN Xiaoyi, ZHANG Yaodong, YANG Xiuan
    Journal of Clinical Pediatrics. 2022, 40(4):  300-305.  doi:10.12372/jcp.2022.21e0540
    Abstract ( 647 )   HTML ( 24 )   PDF (2315KB) ( 346 )  
    Figures and Tables | References | Related Articles | Metrics

    Early-onset epileptic encephalopathy (EOEE) is a kind of epileptic syndrome that appears in neonatal period or early infancy. It has genetic heterogeneity and is characterized by early onset, refractory, multiple seizure types and overall developmental retardation or regression. The clinical data of a child with early-onset epileptic encephalopathy type 27 caused by GRIN2B gene variation were reviewed. The patient was a 12-month-old girl who developed the disease on the second day after birth, presenting with refractory epilepsy, psychomotor retardation, and hypotonia. Cranial magnetic resonance imaging showed bilateral frontal subarachnoid space widening. Long range video electroencephalogram showed multifocal sharp waves and spike waves in each waking and sleeping period, as well as abnormal brain discharges corresponding to the clinical onset, suggesting sharp waves and spike slow waves in the right frontal lobe and central region during sleeping period. Whole exon gene sequencing revealed a novel heterozygous missense variation of c.2635G>A (p. Glu879Lys) (NM_000834) in GRIN2B gene of the proband. The parental and elder brother genotypes were wild-type and the child was considered as early-onset epileptic encephalopathy type 27. No literature was reported on this locus variant. According to the 2015 guidelines of the American College of Medical Genetics and Genomics, it was considered likely pathogenic. Topiramate, ocasepine and rehabilitation function training were used for treatment. During the follow-up, the development of the patient was found to be behind that of normal children of the same age, and there was no epileptic seizure and no abnormal discharge in electroencephalogram. The GRIN2B gene missense variant of (NM_000834):c.2635G>A (p.Glu879Lys) is a possible cause of the proband.

    Early infantile-onset epileptic encephalopathy caused by PARS2 gene variation: a case report
    WANG Xiuying, TIAN Yang, SHI Zhen, HOU Chi, LI Xiaojing, ZHU Haixia, CAO Binbin, CHEN Wenxiong, WU Xiangling
    Journal of Clinical Pediatrics. 2022, 40(4):  306-310.  doi:10.12372/jcp.2022.21e0723
    Abstract ( 661 )   HTML ( 37 )   PDF (3048KB) ( 274 )  
    Figures and Tables | References | Related Articles | Metrics

    Genetic factors are common causes of early infantile-onset epileptic encephalopathy. The pathogenicity variation of a child with early infantile-onset epileptic encephalopathy was reported in this paper. The boy was 4 months and 27 days old. He had recurrent convulsions for more than 20 days, characterized by convulsive seizures and developmental retardation. The proband's parents had no abnormal phenotype. The proband had compound heterozygous variation of c.287G>A (p.Arg96His) and c.283G>A (p.Val95Ile) in PARS2 gene. The former was derived from the mother, and the latter from the father. Among them, the former phenotype has not been reported, while the latter variant of C. 283G>A has been reported in the past. According to the guidelines of the American College of Medical Genetics and Genomics, both of them are considered to be of "unknown significance". After 6 weeks of oral treatment with topiramate and nitrazepam, seizure was controlled, but the child still had significant psychomotor developmental retardation and hypotonia. The results suggested that a novel compound heterozygous variation of PARS2 gene is the pathogenic variation of the child with early infantile-onset epileptic encephalopathy in this family, which provides a basis for genetic counseling in this family. Epileptic encephalopathy caused by PARS2 gene variation still has severe developmental retardation even when seizure is controlled.

    Research progress in the treatment of epilepsy associated with tuberous sclerosis complex
    Reviewer: TIAN Qilong, Reviser: WANG Julei
    Journal of Clinical Pediatrics. 2022, 40(4):  311-315.  doi:10.12372/jcp.2022.21e1280
    Abstract ( 268 )   HTML ( 6 )   PDF (1104KB) ( 171 )  
    References | Related Articles | Metrics

    Patients with tuberous sclerosis complex (TSC) are at high risk of epilepsy, most of which begins in infancy. Excessive activation of mTOR signaling pathway and focal cortical dysplasia are important mechanisms for TSC-related epilepsy. Epileptiform abnormal electrical brain activity can effectively predict the occurrence of subsequent epileptic seizure. Electroencephalogram is the main method of recording epileptic abnormal brain electrical activity. Prophylactic use of vigabatrin will effectively inhibit the chance of TSC-related epilepsy and protect neurodevelopment. Antiepileptic drugs, mTOR inhibitors, epileptic surgery, ketogenic diet and vagal nerve stimulation are commonly used therapeutic schedules for TSC-related epilepsy. In this paper, the latest research progress on the treatment of TSC-related epilepsy will be described.

    Application and prospect of left bundle branch pacing in children with cardiovascular diseases
    XIONG Miao, LYU Tiewei
    Journal of Clinical Pediatrics. 2022, 40(4):  316-320.  doi:10.12372/jcp.2022.21e1257
    Abstract ( 239 )   HTML ( 5 )   PDF (1102KB) ( 288 )  
    References | Related Articles | Metrics

    His bundle pacing (HBP) is a physiological pacing mode of ventricular pacing, which can promote electrical resynchronization and biventricular synchrony. The left bundle branch pacing (LBBP), which was a supplement to HBP, has the advantages of simple operation and better parameters. However, the feasibility and safety of LBBP in children have not been well verified. And the differences in physiological characteristics and heart structure between children and adults are different which mean that the application of LBBP in children needs to be adjusted. In this review, we attempt to discuss the development of LBBP, the advantages of LBBP, the application and adjustment of LBBP in pediatrics, in order to explore the application and prospect of LBBP in children with cardiovascular diseases.